--- # === IDENTITY === id: business/fundraising/safe-vs-convertible-note/2026 canonical_question: "What is the difference between a SAFE and a convertible note — caps, interest, discounts?" aliases: - "SAFE note vs convertible note" - "YC SAFE agreement" - "pre-seed funding instruments" - "convertible debt vs SAFE" entity_type: concept domain: business > fundraising > SAFE vs Convertible Note region: global jurisdiction: global temporal_scope: 2013-2026 # === VERIFICATION === last_verified: 2026-02-28 confidence: 0.91 version: 1.0 first_published: 2026-02-28 # === TEMPORAL VALIDITY === temporal_validity: status: evolving last_breaking_change: "2023-01-01" next_review: 2026-08-27 change_sensitivity: medium # === CONSTRAINTS === constraints: - "Jurisdiction-dependent — SAFEs have no legal status in many non-US jurisdictions; convertible notes are recognized as debt globally" - "Multiple uncapped SAFEs can create severe dilution surprises at conversion that founders discover too late" - "Convertible note maturity dates create legal default risk — if the note matures before a priced round, lenders can demand repayment" - "Neither instrument prices the company — both defer valuation to a future round, creating ambiguity about true ownership" - "Tax treatment varies — SAFEs are equity-like in the US (no interest deduction) while convertible notes are debt (interest accrues)" skip_this_unit_if: - condition: "User is raising a priced equity round (Series A or later) and does not need a bridge instrument" use_instead: "business/fundraising/series-a-readiness/2026" - condition: "User needs to model dilution from multiple instruments on their cap table" use_instead: "business/fundraising/equity-dilution/2026" - condition: "User is deciding on founder vesting terms as part of their formation" use_instead: "business/fundraising/founder-vesting/2026" inputs_needed: - key: "funding_instrument" question: "What type of early-stage funding instrument is the user evaluating?" type: choice options: ["Choosing between SAFE and convertible note", "Understanding SAFE terms (cap, discount)", "Understanding convertible note terms (interest, maturity)", "Modeling conversion into a priced round"] # === DISTRIBUTION === canonical_source: "https://knowledgelib.io/business/fundraising/safe-vs-convertible-note/2026" suggested_citation: "Source: knowledgelib.io — AI Knowledge Library (verified 2026-02-28)" # === RELATED UNITS === related_kos: related_to: - id: "business/fundraising/equity-dilution/2026" label: "Equity Dilution" - id: "business/fundraising/cap-table-management/2026" label: "Cap Table Management" often_confused_with: [] depends_on: [] solves: [] alternative_to: [] # === SOURCES === sources: - id: src1 title: "SAFE vs Convertible Note: Complete Comparison for Startup Funding" author: Promise Legal url: https://www.promise.legal/resources/safe-vs-convertible type: technical_blog published: 2025-01-15 reliability: high - id: src2 title: "Convertible Notes & SAFEs: Still Popular, But Terms Are Tightening" author: Fenwick url: https://whatstrending.fenwick.com/post/convertible-notes-safes-still-popular-but-terms-are-tightening type: industry_report published: 2025-03-01 reliability: authoritative - id: src3 title: "SAFE Note: Definition, Key Components, and Benefits" author: Wall Street Prep url: https://www.wallstreetprep.com/knowledge/safe-note/ type: technical_blog published: 2024-06-01 reliability: high - id: src4 title: "Convertible Notes: What Startups Need to Know in 2025" author: Gilion url: https://www.gilion.com/basics/convertible-notes type: technical_blog published: 2025-02-01 reliability: moderate_high - id: src5 title: "SAFE vs Convertible Note: Complete 2024 Comparison Guide" author: ICanPitch url: https://learn.icanpitch.com/blog/safe-vs-convertible-note-2024-comparison/ type: technical_blog published: 2024-09-15 reliability: moderate_high --- # SAFE vs Convertible Note ## Definition A SAFE (Simple Agreement for Future Equity) is a contractual right to receive equity in a future priced round without creating debt, accruing interest, or having a maturity date — invented by Y Combinator in 2013. A convertible note is a short-term debt instrument that converts to equity at a future priced round, carrying interest (typically 2-8% annually) and a maturity date (12-24 months). Both instruments defer company valuation to a future round and use valuation caps and/or discounts to reward early investors. [src1] ## Key Properties - **Legal nature**: SAFE is equity-like (not debt); convertible note is debt that converts to equity [src1] - **Interest**: SAFEs accrue no interest; convertible notes accrue 2-8% annually, added to principal at conversion [src4] - **Maturity date**: SAFEs have none; convertible notes mature in 12-24 months (creates default risk if no priced round occurs) [src2] - **Closing speed**: SAFEs close in ~1.8 weeks from term sheet; convertible notes take ~4.2 weeks [src5] - **Market share (2024)**: 88% of pre-priced rounds use SAFEs; 78% of YC companies use SAFEs vs. 12% convertible notes [src1] - **Valuation cap**: Both instruments can include a cap — the maximum valuation at which the investment converts to equity [src3] - **Discount rate**: Both typically include a 15-25% discount on the next round's price per share [src4] ## Constraints - SAFEs have limited legal recognition outside the US — in many jurisdictions convertible notes are the only option [src1] - Stacking multiple SAFEs without tracking the cap table creates dilution surprises at Series A conversion [src2] - Convertible note maturity creates legal risk — if a priced round does not close before maturity, note holders can demand repayment [src4] - Neither instrument establishes a company valuation — both defer pricing, which creates uncertainty about true ownership until conversion [src3] - Interest rates on convertible notes rose 200-300 bps in 2024-2025 as terms tightened [src2] ## Framework Selection Decision Tree ``` START — Founder needs pre-seed/seed funding ├── Is the company incorporated in the US (Delaware C-Corp)? │ ├── YES → SAFE is the default instrument (88% market share) │ └── NO → Check local jurisdiction; convertible note may be required ├── What's the investor preference? │ ├── Angels / accelerators → SAFE (faster, simpler, no maturity risk) │ ├── Institutional seed → SAFE with cap + discount (or priced round) │ └── Bridge between rounds → Convertible note (investors want debt priority) ├── Is there a near-term priced round expected? │ ├── YES (< 6 months) → Either works; SAFE is faster │ └── NO (> 12 months) → SAFE preferred (no maturity default risk) └── Does the investor require interest accrual? ├── YES → Convertible note ← REQUIRED └── NO → SAFE ← YOU ARE HERE (most cases) ``` ## Application Checklist ### Step 1: Choose the instrument - **Inputs needed**: Jurisdiction, investor type, expected timeline to next priced round - **Output**: Decision: SAFE or convertible note - **Constraint**: If outside the US, verify that SAFEs are legally enforceable in your jurisdiction before proceeding [src1] ### Step 2: Set the valuation cap - **Inputs needed**: Current traction, comparable pre-seed/seed valuations, amount being raised - **Output**: Cap amount (e.g., $8M cap for a $1M SAFE raise) - **Constraint**: An uncapped SAFE is extremely founder-unfavorable; avoid unless the investor demands it and the amount is small. Multiple uncapped SAFEs compound dilution unpredictably [src2] ### Step 3: Set the discount rate - **Inputs needed**: Investor's required return, expected time to conversion, market norms - **Output**: Discount percentage (typically 15-25%) - **Constraint**: Cap and discount interact — investors get the more favorable of the two at conversion. Model both scenarios before signing [src3] ### Step 4: Model conversion scenarios - **Inputs needed**: SAFE/note amount, cap, discount, expected Series A valuation, option pool size - **Output**: Pro-forma cap table showing post-conversion ownership - **Constraint**: Always model the "worst case" where Series A valuation exceeds the cap significantly — this shows maximum dilution from the instrument [src5] ### Step 5: Execute and track on cap table - **Inputs needed**: Signed instrument, payment confirmation - **Output**: Updated cap table with convertible securities listed as outstanding - **Constraint**: Every SAFE/note must be tracked on the cap table immediately, not at conversion — failure to track creates legal and financial surprises [src2] ## Anti-Patterns ### Wrong: Raising multiple uncapped SAFEs assuming dilution will be minimal Founders who raise 3-4 uncapped SAFEs totaling $2M assume dilution is manageable. At Series A conversion, they discover that uncapped SAFEs convert at the Series A price, giving early investors far more equity than expected. [src2] ### Correct: Always include a valuation cap and model cumulative dilution Set a cap on every SAFE, then use a cap table tool to model what happens when all SAFEs convert at the next round. Stack all outstanding instruments to see true dilution. [src3] ### Wrong: Ignoring convertible note maturity dates Founders treat maturity as a formality, assuming investors will extend. When a priced round stalls, noteholders can legally demand repayment, potentially forcing bankruptcy or fire-sale terms. [src4] ### Correct: Negotiate extension provisions upfront Include an automatic extension clause (e.g., 6-month extension at mutual consent) in the convertible note. Alternatively, use a SAFE to avoid maturity risk entirely. [src1] ### Wrong: Choosing an instrument based solely on speed "SAFEs are faster so they are always better" ignores situations where convertible notes are strategically superior — bridge rounds, international investors, or when interest accrual aligns incentives. [src5] ### Correct: Match instrument to situation Use SAFEs for initial pre-seed/seed raises (speed + simplicity). Use convertible notes for bridge rounds, international contexts, or when investors require debt-like protections. [src1] ## Common Misconceptions - **Misconception**: SAFEs are "free money" because they are not debt and have no maturity date. **Reality**: SAFEs are a contractual right to future equity. They always convert, diluting founders at the next priced round. The absence of a maturity date does not reduce their economic impact — it just removes the time pressure. [src3] - **Misconception**: A valuation cap means the company is valued at that amount today. **Reality**: A cap is a ceiling on conversion price, not a valuation. A $10M cap SAFE in a company with no revenue does not mean the company is worth $10M — it means the investor converts at no more than $10M regardless of the next round's valuation. [src1] - **Misconception**: Interest on convertible notes is paid in cash. **Reality**: Convertible note interest is almost never paid in cash. It accrues and is added to the principal, which then converts to equity. A $500K note at 6% interest for 18 months converts as ~$545K of equity. [src4] - **Misconception**: Discounts and caps are interchangeable negotiation levers. **Reality**: They serve different functions. The cap protects against upside (company valued much higher at Series A). The discount rewards the investor for timing risk. At conversion, investors get whichever gives them the lower price per share. [src5] ## Comparison with Similar Concepts | Concept | Key Difference | When to Use | |---|---|---| | SAFE | Equity-like, no debt, no maturity, no interest | Default for US pre-seed/seed; fastest to close | | Convertible Note | Debt instrument with interest + maturity date | Bridge rounds, international, when debt status needed | | Priced Equity Round | Sets a fixed valuation and price per share | Series A and beyond; when company has sufficient traction to price | | Revenue-Based Financing | Repaid as % of revenue, no equity conversion | When founders want to avoid dilution entirely | ## When This Matters Fetch this when a founder asks about early-stage funding instruments, is comparing SAFEs to convertible notes, needs to understand valuation caps or discounts, or is deciding which instrument to use for a pre-seed or seed raise. ## Related Units - [Equity Dilution](/business/fundraising/equity-dilution/2026) - [Cap Table Management](/business/fundraising/cap-table-management/2026) - [Series A Readiness](/business/fundraising/series-a-readiness/2026)